SHARPE
Reported results
- Consolidated revenues were $827.4 million for Q3 2026, with a year-over-year change of -15.5%.
- Consolidated gross profit for Q3 2026 was $124.1 million, with a gross profit percentage of 15.0%.
- Consolidated operating loss for Q3 2026 was $9.1 million, with an operating loss percentage of -1.1%.
- Net loss attributable to stockholders was $14.9 million for Q3 2026.
- Under the Non-GAAP Reconciliation of ROTCE, the actual return on total capital employed percentage for 2026 was (10.7)%.
Notes
Historical and current results of the former Nuvera segment are now presented within the Americas operating segment.
Price and volatility reaction
The stock moved +5.4% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -14.4 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 26.95 | 2026-11-05 |
| Close after release | 28.41 | 2026-11-06 |
| Realised move | +5.4% | close to close |
| 30d ATM IV change | -14.4 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-05 (8-K, Item 2.02). Read the original filing on sec.gov.